DE60023180D1 - Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten - Google Patents

Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten

Info

Publication number
DE60023180D1
DE60023180D1 DE60023180T DE60023180T DE60023180D1 DE 60023180 D1 DE60023180 D1 DE 60023180D1 DE 60023180 T DE60023180 T DE 60023180T DE 60023180 T DE60023180 T DE 60023180T DE 60023180 D1 DE60023180 D1 DE 60023180D1
Authority
DE
Germany
Prior art keywords
lithium
treatment
diithium
grange
viral infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60023180T
Other languages
English (en)
Inventor
Edward Hartley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henderson Morley Research and Development Ltd
Original Assignee
Henderson Morley Research and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930813.2A external-priority patent/GB9930813D0/en
Priority claimed from GB0000683A external-priority patent/GB0000683D0/en
Priority claimed from GB0023200A external-priority patent/GB0023200D0/en
Application filed by Henderson Morley Research and Development Ltd filed Critical Henderson Morley Research and Development Ltd
Application granted granted Critical
Publication of DE60023180D1 publication Critical patent/DE60023180D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60023180T 1999-12-30 2000-12-13 Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten Expired - Lifetime DE60023180D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9930813.2A GB9930813D0 (en) 1999-10-15 1999-12-30 Anti-viral treatment
GB0000683A GB0000683D0 (en) 1999-10-15 2000-01-12 Antiviral treatment
GB0023200A GB0023200D0 (en) 1999-12-30 2000-09-21 Synergistic treatment of DNA viral infections
PCT/GB2000/004790 WO2001049300A2 (en) 1999-12-30 2000-12-13 Combinations for the treatment of dna viral infections comprising a loop diuretic and lithium

Publications (1)

Publication Number Publication Date
DE60023180D1 true DE60023180D1 (de) 2006-02-23

Family

ID=27255466

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60023180T Expired - Lifetime DE60023180D1 (de) 1999-12-30 2000-12-13 Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten

Country Status (9)

Country Link
US (2) US20030049331A1 (de)
EP (1) EP1242096B1 (de)
JP (1) JP2003519186A (de)
KR (1) KR20020073156A (de)
CN (1) CN1213757C (de)
AT (1) ATE306275T1 (de)
AU (1) AU1873101A (de)
DE (1) DE60023180D1 (de)
WO (1) WO2001049300A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60009146T2 (de) * 1999-12-30 2005-02-17 Henderson Morley Research And Development Ltd., Moseley Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten
DE60139134D1 (de) * 2000-09-21 2009-08-13 Henderson Morley Res & Dev Ltd Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung
DE602004029651D1 (de) 2003-02-12 2010-12-02 Univ Georgetown Verwendung von artemisinin zur behandlung von durch onkogene viren gebildeten tumoren und zur behandlung von viralen infektionen
GB2413282B (en) * 2004-04-23 2009-01-14 Henderson Morley Plc DNA Viral Infections
GB0616451D0 (en) * 2006-08-18 2006-09-27 Henderson Morley Plc Dna viral infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
GB8320203D0 (en) * 1983-07-27 1983-09-01 Horrobin D F Anti-viral compositions
GB9023701D0 (en) * 1990-10-31 1990-12-12 Efamol Holdings Medical treatment
DE4127469A1 (de) * 1991-08-20 1993-02-25 Peter Prof Dr Med Eckert Arzneimittel und ihre verwendung
DE69410248T2 (de) * 1993-03-12 1999-01-21 Univ Keele Therapeutische zusammensetzungen die lithiumverbindungen und silika enthalten
WO1995015352A1 (en) * 1993-12-01 1995-06-08 Universite Du Quebec A Montreal Albumin based hydrogel
DE60139134D1 (de) * 2000-09-21 2009-08-13 Henderson Morley Res & Dev Ltd Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung

Also Published As

Publication number Publication date
US20060029684A1 (en) 2006-02-09
WO2001049300A2 (en) 2001-07-12
KR20020073156A (ko) 2002-09-19
JP2003519186A (ja) 2003-06-17
US20030049331A1 (en) 2003-03-13
EP1242096B1 (de) 2005-10-12
WO2001049300A3 (en) 2002-07-11
CN1414859A (zh) 2003-04-30
AU1873101A (en) 2001-07-16
CN1213757C (zh) 2005-08-10
EP1242096A2 (de) 2002-09-25
ATE306275T1 (de) 2005-10-15

Similar Documents

Publication Publication Date Title
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE69713287T2 (de) Verbindungen von wirkstoffen, welche klopidogrel und antithrombotische mittel enthalten
DE3787002D1 (de) Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen.
ATE261737T1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten
DE69107946D1 (de) Adhäsive Präparation zur Förderung der Regenierung verletzter Nerven und klebende pharmazeutische Zubereitungen dafür.
BG103786A (bg) Състав и метод за профилактика и лечение на нiv и други инфекциозни заболявания при човека
GEP19991834B (en) Crystalline Oxathiolane Derivatives
DE69802260T2 (de) Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
NO20020571L (no) Peptider som blokkerer infeksjonsevnen, og fremgangsmåter for anvendelse av disse
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
DE58909850D1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
FI935780A (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
DE60023180D1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten
DE69006676T2 (de) Tripeptidverbindungen und ihre pharmazeutische Anwendung als Immunmodulatoren.
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
DE69916488D1 (de) Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
DE69817379D1 (de) Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne
MA26650A1 (fr) Oxo-thia -azabicyclooctenes, preparations pharmaceutiques les contenant, et leur utilisation pour le traitement et la prophylaxie de maladies infectieuses.
EE03514B1 (et) Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
ES2191206T3 (es) Nueva utilizacion de la creatina.
DE60024969D1 (de) 2-methyl-3-butenyl-1-pyrophosphorsäuresalze und mittel zur behandlung von lymphozyten
MA26657A1 (fr) Derives de cephalosporine, procede pour les preparer, medicaments les contenant, et leur utilisation dans le traitement de la prophylaxie de maladies infectieuses.
DE69825307D1 (de) Verwendung von protein h als zytostattischer wirkstoff

Legal Events

Date Code Title Description
8332 No legal effect for de